Hola Prime's compliance structure is a 24/7 Compliance Review system designed to ensure fair and ethical trading practices. A ...

- The MarketingPulse and eTailingPulse conferences ran in parallel at the Hong Kong Convention and Exhibition Centre (HKCEC) today, attracting more than 1,600 industry professionals from 22 countries ...

Q2 Metals Intercepts 179.6 Metres of Continuous Spodumene Pegmatite in Large Step-Out at the Cisco Lithium Project in Quebec, ...

Spritzer Sparkling is also adding to the Raya cheer through Malaysian film and television fans by hosting a special Meet & ...

SAESOL Tech has been closely participating in the Interoperability Technical Working Group (ITWG) hosted by USDOT. Recently, ...

HONG KONG, Mar 19, 2025 - (ACN Newswire) - Kingsoft Corporation Limited (“Kingsoft” or the “Company”; HKEx stock code: 03888), a leading Chinese software and Internet service company, has announced ...

香港, 2025年3月19日 - (亞太商訊) - 今日，雲頂新耀宣佈正式啟動伊曲莫德（VELSIPITY®）位於嘉善工廠的生產建設項目，以支持該藥物的本地化生產，進一步滿足中國及亞洲市場對潰瘍性結腸炎（UC）治療的需求。該項目總投資達7000萬元，預計投產後年產能可達5000萬片，供應範圍涵蓋中國大陸、中國香港、中國澳門、中國台灣、韓國及新加坡等市場。

随着溃疡性结肠炎（UC）患者数量的持续增长，中国市场对创新疗法的需求日益迫切。预计到2030年，中国溃疡性结肠炎患者将增至约100万，对更高效、安全、便捷的治疗方案提出了更高要求。伊曲莫德是一款每日一次口服的一线先进疗法，适用于中重度活动性UC患者，具有快速起效、临床缓解、黏膜愈合及良好安全性等优势。该药物已在多个国家和地区获批，并在2024年12月获中国国家药品监督管理局（NMPA）正式受理新药 ...

Tokyo Century Corporation: TRENDE will collaborate closely with Tokyo Century in finance and asset management to scale its renewable energy leasing services, enabling more residential customers to ...

深圳, 2025年3月19日 - (亞太商訊) - ...

目前，多款MASH在研药物已进入临床后期，然而单一机制药物往往难以兼顾MASH治疗的多重需求：既改善肝脏脂肪变性，又抑制肝脏炎症及纤维化，同时为MASH关联的代谢共病（如，糖尿病、肥胖、心血管疾病等）带来治疗获益。因此，具备多靶点、多功能作用的创新疗法正成为新的研发趋势。